# BioCardia, Inc.: Form 8-K, filed Mar 29, 2023

- Company: [BioCardia, Inc.](/companies/bcda.md) (CIK 925741)
- Form: 8-K
- Filed: 2023-03-29
- Accepted by EDGAR: Mar 29, 2023, 08:16 ET
- Period: 2023-03-29
- Accession: 0001437749-23-008313
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/925741/000143774923008313/bcda20230328_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/925741/000143774923008313/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/925741/000143774923008313/bcda20230328_8k.htm

Filed Mar 29, 2023.
Source: SEC EDGAR, the filing index for accession 0001437749-23-008313. Last ingested by Listed: Nov 10, 2026, 21:12 ET. No prices; not investment advice.
